Feb 7
News
PDF Print E-mail

Quarter Ended 30 September 2011

Global Macro and Markets Overview
Global equity markets weakened materially as yields in government bonds hit historical lows.  Investors' concerns focused on a global slowdown and continued European sovereign risk issues.  The Federal Reserve became more bearish with regard the future outlook as it announced that it would keep interest rates at exceptionally low levels until 2013.  It initiated "Operation Twist" which is the buying of longer dated US government treasuries.  It is hoped this will reduce the borrowing rates associated with long term debt. 

In the US negative headlines surrounded the lack of progress on introducing a long term deficit reduction plan.  The solution which transpired in early August was seen as a short term fix.  Due to the political ramifications with regard the budget deficit S&P downgraded its long term credit rating of the US from AAA to AA+ with a negative outlook.  We do not expect much more progress on this particular issue prior to the election of next year. 

The ECB downgraded growth forecasts for 2011 and 2012.  Meanwhile the Troika experienced conflict with the Greek government and the introduction of an appropriate fiscal policy.  During Q3 a number of European countries voted for the approval of increasing the EFSF.  Some commentators suggested that this fund would have to be leveraged.  It is ironic and worrying that the credit crisis, which resulted from excessive leverage, may need a solution which will entail leveraging the rescue fund. 

The concerns with regard asset values and sovereign debt concerns ensured a flow of funds into gold and what is perceived as defensive currencies.  However, as emphasised by the move from the Swiss National Bank to peg their currency to the Euro at 1.20 investing in currencies remains a volatile exercise. 

The drip feed of negative headlines with regard the European solution continued unabated throughout the quarter.  These included the necessary approval of the EFSF by the German Federal Constitutional Court, the reluctance of the Berlusconi government to introduce an austerity package and the forcing of the Greek government in introducing a property tax.  Italian and Spanish government bond yields increased to worrying levels with the ultimate arrival of the ECB as a buyer of last resort.  The lack of political leadership and the extended time taken for any proposed solution to the European sovereign debt crisis will ensure that markets will remain volatile in the near future.

Nestlé and Unilever
Two consumer staple companies which are Appian equity holdings are Nestlé and Unilever.  High quality consumer staple stocks are strong fits for our preference for companies with 'defensive growth' characteristics.  As the prospects for both of these companies are not overly dependent on the vagaries of the economic cycle, their defensive aspects pay off in turbulent equity markets (for example, in Q3 Nestlé's share price fell by 4% while Unilver's actually gained 5%).  Moreover, both companies have sustainable business models that will generate growth and have strong balance sheets to support this growth.  Both are well placed to grow sales organically by a low to mid single percentage annual rate over the medium to longer term.  Much of this will be volume growth - developing sales in emerging markets, winning market share and expanding their product ranges in all markets.  Some of the revenue expansion will be value growth, partly through higher prices (to reflect higher commodity costs) and partly through mix as higher value added products are focused on.  Furthermore, continual efficiency and cost savings programmes will not only absorb the element of rising commodity costs that cannot be recovered in pricing but will allow margin expansion, reinforcing the prospects for profit growth.  Finally, while investors wait for this potential to be realised they will be rewarded by a dividend yield of 4%. 

As always, if you have any queries in relation to your investment or portfolio, please feel free to contact me or my colleagues.  If you feel it to be beneficial, please do not hesitate to contact us to organise a meeting where we can discuss our investment views in greater detail. 

Pat Kilduff
Investment Manager
October 2011

 
PDF Print E-mail

Quarter Ended 30 June 2011

Global Macro and Markets Overview
Equity and currency markets remained heavily influenced by macro economic issues.  These issues included (1) US debt ceiling (2) Eurozone sovereign issues (3) commodity prices (4) China slowdown (5) the end of QE2 and (6) Japanese supply chain disruptions.  Outlined below is a brief synopsis of these issues.

A US debt ceiling has been in place since 1917.  Presently it is capped at $14.3tr which is likely to be reached by 2 August.  Democrats and Republicans in the year before the election are using the debt ceiling to outline their future fiscal policy initiatives.  Investors believe, based on the fact that the debt ceiling has been raised 74 times since 1962, that it will be increased prior to 2 August.  However, continued speculation of a possible US default is making markets very nervous. 

Our confidence in the Eurozone project has been severely tested as politicians remain permanently behind the curve.  The bond market, despite political protestations about the rating agencies, has indicated its thoughts with regard to the handling of this issue.  At the time of this letter 10 year bond yields for Greece (17.10%), Portugal (12.28%), Ireland (13.69%), Italy (5.86%) and Spain (6.21%) had spiked significantly over their German (2.64%) counterpart.   Based on these bond yields the market is pricing in a series of defaults and hopefully forcing European politicians into enacting appropriate corrective action that Appian has long advocated.  We continue to remain acutely aware of the risks associated with this issue. 

Commodity prices spent most of Qtr 2 at elevated levels.  This remains a concern for us as Corporations begin to report Q2 earnings and analysts have expectations of record margins.  We think there will be greater margin pressure and hence analysts may have overestimated their expected earnings.  However, the recent release of emergency oil supplies from the IEA will provide some short term relief. 

Chinese politicians are attempting to construct a soft landing of the economy.  There is a concern amongst the ruling class that there may be a property bubble and high food prices provide a timely reminder that social unrest remains a continuing concern.  The authorities wish to slow the level of investment in the economy and at the same time encourage consumer spending.  This slowdown will not only effect neighbouring emerging market countries but also those countries that are rich in natural resources. 

The benefits of QE2 are difficult to evaluate but in all likelihood it was beneficial for risk assets such as equities.  QE2 was the $600bn purchasing program of US treasuries by the Federal Reserve as the Fed Funds rate had been lowered to close to 0%.  It enabled bonds yields to remain artificially low and may have provided US exporters with a weaker dollar.  This program ended on 30 June and whilst this should be considered a relative negative we believe the Federal Reserve will keep interest rates at historically low levels until there is sustainable  growth in employment.  The possibility of QE3 should not be discounted. 

The after effects of the Japanese Tsunami and earthquake have been more negative in disrupting global manufacturing than originally anticipated.  However, we suspect the fiscal stimuli provided by the Japanese government will be beneficial for global growth in H2. 

In the short term we remain comfortable with a suitable exposure to appropriate equities (as outlined below) based on their relative valuation to other asset classes and continuing monetary support.  Highly rated bonds, whilst outperforming in the short term, remain overvalued.  Appian remains wary of the effects of future inflation on the real return for bonds.  The security of our cash holding remains a serious consideration as we move funds from commercial bank deposits to short dated German government bonds.  We remain hesitant in materially increasing our clients risk exposure until we get greater transparency on the issues discussed. 

Henkel
Even in times of difficult conditions there are some individual stocks that perform well.  One such stock in Appian's equity portfolio is Henkel, the German producer of household products (Persil), personal care goods (Schwarzkopf) and adhesives (Loctite).  We invested in Henkel in Q3 of last year as we were attracted by its management's determination to generate efficiences and to impose more rigorous systems to boost sales growth and profit margins in its business.  Since then management has delivered - margins have expanded as significant cost savings have been realised and sales growth rates improved.  The company has so far exceeded its targets giving confidence it can achieve the medium-term goals it has set itself.  Consequently, the share price has benefited, rising by 10% over Q2 and it is now approximately 20% above our entry point. 

Novartis
A recent new addition to the equity portfolio was Novartis, the Swiss based global pharmaceutical giant.  The pharma sector is one where we have been underweight and after a consistent de-rating of the valuations of pharma stocks over the past decade we are beginning to sense value - particularly as it is value in a defensive sector against a background of growing macro-economic threats.  We were attracted to Novartis in particular because it has a strong balance sheet, a better than sector average dividend yield (4.5% versus 3.5% for the sector), a well diversified business and an interesting pipeline of potential new products spread across four new emerging franchises.  Simply put, a candidate that matches Appian's preference for high quality, large cap stocks which have defensive growth characteristics at attractive valuations. 

Northern Trust
Post the acquisition of Bank of Ireland Securities Services by Northern Trust client assets will now be held under the custodial stewardship of Northern Trust.  Northern Trust is a global leader in custodial duties with circa $4.4trillion in assets under custody.  As with every aspect of a clients portfolio Appian will continue to review and seek the most appropriate structure and custodian for your assets.

Pat Kilduff
Investment Manager
July 2011

 
PDF Print E-mail

Appian Asset Management and Custom House Capital

Following Central Bank intervention, Appian Asset Management Limited ("Appian") is terminating all its previously announced arrangements with Custom House Capital Limited ("CHC") and related to CHC arising from the agreement whereby Appian was to become the Investment Manager of approximately €250million of non-property assets held by CHC.

A copy letter dated 13 July 2011 to Appian from the Central Bank clarifying Appian's role in this matter is below. 

All of these CHC related matters have no impact whatsoever on Appian clients or any of Appian's clients' assets or investments with Appian.

Appian clients who have any queries should contact their Appian relationship manager or investment portfolio adviser.

To read more click here to view the Irish Times article.

CHC clients should contact Custom House Capital on 01 6325180.

Letter from Central Bank of Ireland

 letter from central bank thumb

 
PDF Print E-mail

Quarter Ended 31 March 2011

Global Macro and Markets Overview
Equity and currency markets suffered significant volatility in the first quarter of 2011.  Initially the equity market benefited from better than expected earnings in Q1.  This combined with PMI and ISM figures showng a significant expansion in the service and manufacturing sectors provided impetus to the equity market.  Equities also benefited from on-going mergers and acquisition activity and improving employment figures.  However, in the latter half of the quarter equity markets suffered as a result of geopolitical volatility in North Africa and the Middle East and the natural disasters that struck Japan.  As a result of the problems in the Middle East and North Africa the price of a barrel of oil spiked to $115.  Inflationary pressures increased as a result of higher energy costs and food prices.  Higher food prices have proven to be the catalyst for the geopolitical concerns in the Middle East and North Africa. 

Risks associated with the Eurozone sovereign government debt continue to materialise with little impetus from the ECB or European Commission in implementing a practical medium to long term solution.  As a result of inflationary pressures the ECB has signaled to the market that it will begin the process of increasing interest rates.  This is a reflection of higher than expected inflation in the Eurozone and continued above par growth in core European countries.  The signposted increase in interest rates in the Eurozone has seen the Euro significantly strengthen versus the US Dollar. 

There remain significant risks with regard to the macro economic environment.  These include:  (1) the possibility of a hard landing in emerging markets; (2) continued currency volatility; (3) the difficulty in ultimately quantifying the issues surrounding Japan, North Africa and the Middle East; (4) continued weakness in the property market in the US and the effect that has on consumer spending; and (5) the possibility that QE2 (US quantitative easing, round 2) will cease at the end of June and the effects this might have on asset values.

Pfizer and Humana
Two US health related stocks common among our equity holdings, Pfizer and Humana, performed strongly in the first quarter.  Both companies have strong balance sheets and were lowly valued (at less than 10 times earnings) at end 2010, reinforcing our view that attractively valued companies, with sustainable business models and low financial risk provide attractive and sensible investment opportunities.

US pharma giant Pfizer rose 16% helped by two developments.  FIrstly, it raised its target for annual cost savings from the $68bn acquisition of Wyeth just a year earlier to $4bn, implying that the cost savings alone from this deal represent a return of 6% on the investment.  Secondly, Pfizer's management concede that it is sympathetic to the idea of possibly separating out the group's consumer products and pharmaceutical business which investors believe may allow each division to be better valued by the market.

Humana is a provider of healthcare services and other health insurance products in the US.  Its shares gained 28% in the first three months of 2011 as investors recognised that the various healthcare reforms championed by either political bloc in the US are likely to be favourable to its business.  Meanwhile it continues to successfully enroll new customers, highlighting the existing positive trends it is benefiting from.

Pat Kilduff 
Investment Manager
March 2011  

 

 
PDF Print E-mail

Global Franchises - The low risk approach to diversifying overseas

Too much (local) knowledge can be dangerous

Sunday Business Post - December 26th 2010
by John Mattimoe, Senior Portfolio Manager, Appian Asset Management

The Irish equity market has been caught in the crossfire of the turmoil afflicting the Irish bond market.  All Irish financial assets have been tarred with the same brush by international investors and there is little discrimination between quality assets and those that are genuinely toxic.  In that context there now is, at best, major apathy towards Irish equities from institutional investors, and this indifference may well persist for as long as it takes Ireland to regain the confidence of the bond market - which is likely to be well along the four year plan to stabilise the public finances. 

Consequently, those investors whose interest in equities has predominantly been in Irish stocks may now need to internationalise their investment universe.  However, many such investors have shown reluctance over the years to diversify equity holding outside of Ireland.  While this in part was due to the good returns generated by Irish equities in teh 1993-2006 period, it also reflects (i) a belief that local knowledge was an advantage in Irish equities, and (ii) concern that the risks associated with far away hills were not as manageable. 

Looking at the first of these issues, we would challenge how valuable local knowledge has been.  Indeed, sometimes being too close to the ground can be a distinct disadvantage - anyone who bought Irish banks shares because they heard someone from one of the banks in the pub at the weekend saying everything was grand and there was nothing to worry about can painfully testify to this.  Also, many leading quoted Irish industrial companies, such as CRH, Ryanair, Aryzta, Kerry and DCC, have profitably diversified away from Ireland over the years, to the extent that in most cases, the proportion of their business in Ireland is 10% or less.  In that context, Irish investors are not best placed for getting local knowledge about what is happening on the ground for these businesses in the US, Britain or continental Europe. 

Risk analysis on potential equity investments is critical, and just because a stock might not be based in Ireland does not mean that a sound assessment cannot be made, particularly if basic principles are applied.  Granted, it is easy to get excited and bamboozled in equal measures by exotic sounding opportunities.  For example, emerging markets promise much in terms of economic growth potential, but the valuations of many equities in these areas already discount much of that potential, while a lot of potential investors are correct in wanting to satisfy themselves on concerns over corporate governance, accounting standards and market regulations before jumping into emerging markets. 

However, keeping things simple and sticking to basic valuation principles is a sensible way to manage the risk of diversifying into overseas equities.  An effective example of keeping it simple that we in Appian like is a portfolio of Global Franchise stocks - for illustration we have chosen the following half dozen: Coca Cola, Colgate Palmolive, Johnson & Johnson, Nestlé, Unilever and Wal-Mart.  These are large, blue chip companies which offer defensive growth characteristics. 

They are defensive because they have scale, strong and established brands, reasonable pricing dynamics, low costs and they serve markets which have robust demand characteristics - the demand for and the pricing and profitability of products like Coke, Nescafé and Persil tend to perform better than most products during downturns.  These companies also have stronger balance sheets, with an average debt / equity ratio of 15%, nearly half that of the market  average.  Not only does this mean the financial risk wihin these stocks is lower, it enables them to better sustain dividend payouts, growth of dividend and investment back into their businesses. 

The Global Franchises also offer growth characteristics by adding to their product range and expanding geographically.  A product acquired or newly developed by a Global Franchise company can reap the benefits of their massive distribution capability - for example, Unilever recently acquired the producer of Alberto V05 hair-care products which were predominantly sold in the US and to a lesser extent in Europe, but Unilever can now use its network to develop markets for these products in Latin America and Asia.  Geographic growth is being successfully pursued through the penetration of new markets.  In particular these are mostly emerging markets where the Global Franchises will not only benefit from fast rates of population growth, but they will also prosper from growing demand for western and global brands as wealth levels rise.  Indeed, we in Appian would argue that with the Global Franchises generating significant proportions of their business (nearly 50% in the case of Unilever) from emerging markets, that they represent a low risk way for western investors to get exposure to those markets. 

Finally, the financial characteristics of the Global Franchises compare well against the broader market.  At the time of writing, the weighted average 2011 price / earnings ratio of the six which we have highlighted is 14.5x, based on consensus forecasts.  While this is slightly higher than the market average of 13.2x this premium is more than justified by the superior earnings growth record of the six Global Franchises.  These, over the past decade, have grown earnings per share by 9% p.a. on average compared to just 2% for the market average.  The average 2011 dividend yield of the six is an expected 2.9%, higher than the market average of 2.5%.  To put that in context this 2.9% yield is similar to German 10 year bond yields and just below the US 10 year bond yield of 3.3%.  This is attractive given these companies have delivered average dividend growth of 13% p.a. over the last ten years, a period where the market average has shown a decline of 3% p.a. 

Based on these metrics, we would argue that Global Franchises offer a relatively low risk opportunity among international equities. 

 

 

 

 
  • «
  •  Start 
  •  Prev 
  •  1 
  •  2 
  •  3 
  •  4 
  •  Next 
  •  End 
  • »


Page 1 of 4